The fields of technology and healthcare have always been closely connected. The advancements made in science form the foundation of modern medicine, from curing diseases and facilitating surgeries to playing a crucial role in early diagnosis. Recently, many technology companies like Apple have focused on bringing health solutions to the forefront through their products. We have already reported on Gizmochina about how the Apple Watch can pre-detect some heart conditions. Now, a similar move has come from South Korea. Samsung has announced that it is supporting the digital diagnosis of Alzheimer through the use of the Galaxy Tab S8+. Here are the details…

Samsung’s Galaxy Tab S8+ to Play Major Role in Digital Alzheimer Diagnosis

Samsung has announced that it is supporting the digital diagnosis of Alzheimer using the Galaxy Tab S8+ Enterprise Edition. The company’s Swiss subsidiary has collaborated with Bottneuro AG, a medical technology startup, to conduct research on the development of an Alzheimer’s diagnosis solution.

samsung galaxy tab s8 as a alzheimer diagnosis tool

Bottneuro has developed technology that identifies the brain area where Alzheimer occurs through 3D MRI and PET data, and conducts electric target treatment with the self-developed neurostimulator ‘Mia Mind’. The Galaxy Tab S8+ is used to control the neurostimulator and transmit treatment data. This development makes early diagnosis much easier and accessible.

The solution developed through this research will be provided to clinical patients in hospitals in Switzerland. Samsung plans to supply 100 Galaxy Tab S8+ products in June, with the number of units supplied set to increase to 2,500 by the end of this year. The company aims to expand product supply to various regions, including Europe, next year.

The use of digital diagnosis for Alzheimer’s disease is becoming increasingly important as the global population ages. According to the World Health Organization (WHO), there are currently around 50 million people worldwide with dementia, with Alzheimer’s disease being the most common form. This number is expected to triple by 2050.

According to the World Health Organization (WHO), an estimated 50 million people worldwide suffer from dementia, and Alzheimer’s disease accounts for 60-70% of dementia cases. In 2021, the number of people with dementia is projected to be approximately 55 million, and this number is expected to increase to 78 million by 2030 and 139 million by 2050, due to the aging of the global population.

RELATED:

(source)